R. Holma et al., Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats, SC J GASTR, 36(6), 2001, pp. 630-635
Background: Certain lactobacilli reduce the severity of experimental coliti
s. The aim of this study was to compare the effects of a human strain Lacto
bacillus rhamnosus GG and a rat strain Lactobacillus reuteri R2LC on acetic
acid-induced colitis in rats. Methods: Lactobacillus rhamnosus GG, Lactoba
cillus reuteri R2LC or sulphasalazine were given orally to the rats. Coliti
s was assessed 72 h after induction with acetic acid. Results: Lactobacillu
s reuteri R2LC significantly antagonized body weight loss caused by inflamm
ation compared with Lactobacillus rhamnosus GG and sulphasalazine. and oede
ma formation in the colon compared with sulphasalazine. Lactobacillus reute
ri R2LC reduced the median value of macroscopic ulceration and the protein
content of inducible nitric oxide synthase by 50% and the median of the pro
tein content of inducible cyclooxygenase by 30% compared with that of the c
olitis control group, and Lactobacillus rhamnosus GG reduced the median of
inducible nitric oxide protein content by 40% and increased the median of i
nducible cyclooxygenase protein content by 30% compared with the median val
ue of the colitis control group, but these differences were nut statistical
ly significant. Conclusions: The rat strain Lactobacillus reuteri R2LC, but
not the human strain Lactobacillus rhamnosus GG, is of benefit in reducing
the severity of acetic acid-induced colitis in rats. These results suggest
that it is not the total amount of Lactobacillus but the particular specie
s or strain of Lactobacillus that is important in attenuating experimental
colitis.